{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:18:42Z","timestamp":1770837522481,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.vaccine.2007.11.021","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T14:54:59Z","timestamp":1196866499000},"page":"333-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response"],"prefix":"10.1016","volume":"26","author":[{"given":"I.","family":"Ramos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Marcen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Peris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Colmenares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Larraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.11.021_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1051\/parasite\/1990653111","article-title":"Taxonomy in Leishmania: use of zymodemes. Suggestions for a new classification","volume":"65","author":"Rioux","year":"1990","journal-title":"Ann Parasitol Hum Comp"},{"key":"10.1016\/j.vaccine.2007.11.021_bib2","volume":"vol. 1","author":"Peters","year":"1987"},{"key":"10.1016\/j.vaccine.2007.11.021_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(04)57001-X","article-title":"Canine leishmaniasis","volume":"57","author":"Alvar","year":"2004","journal-title":"Adv Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.021_bib4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0035-9203(86)90344-5","article-title":"Leishmaniasis in Sardinia. II. Natural infection of Phlebotomus perniciosus Newstead, 1911, by Leishmania infantum Nicolle, 1908, in the province of Cagliari","volume":"80","author":"Bettini","year":"1986","journal-title":"Trans Roy Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.021_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-4017(97)00208-2","article-title":"The immunology of canine leishmaniosis: strong evidence for a developing disease spectrum from asymptomatic dogs","volume":"76","author":"Cabral","year":"1998","journal-title":"Vet Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.021_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4269\/ajtmh.1996.55.273","article-title":"Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting","volume":"55","author":"Berrahal","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.021_bib7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/JCM.39.2.560-563.2001","article-title":"Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology","volume":"39","author":"Solano-Gallego","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.021_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis: is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.vaccine.2007.11.021_bib9","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2174\/092986707780362862","article-title":"Chemotherapy of leishmaniasis: past, present and future","volume":"14","author":"Mishra","year":"2007","journal-title":"Curr Med Chem"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.021_bib10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10096-005-1342-6","article-title":"Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region","volume":"24","author":"Pasquau","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.021_bib11","first-page":"357","article-title":"Leishmania\/HIV co-infections in the second decade","volume":"123","author":"Cruz","year":"2006","journal-title":"Indian J Med Res"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.021_bib12","first-page":"441","article-title":"Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes","volume":"30","author":"Lasri","year":"1999","journal-title":"Vet Res"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.021_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1590\/S0074-02761996000600006","article-title":"Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs","volume":"91","author":"Mayrink","year":"1996","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"40","key":"10.1016\/j.vaccine.2007.11.021_bib14","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1016\/j.vaccine.2005.05.011","article-title":"Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs","volume":"23","author":"Nogueira","year":"2005","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.11.021_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00315-X","article-title":"A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum","volume":"92","author":"Molano","year":"2003","journal-title":"Vet Immunol Immunopathol"},{"issue":"22","key":"10.1016\/j.vaccine.2007.11.021_bib16","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","article-title":"Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes","volume":"23","author":"Lemesre","year":"2005","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2007.11.021_bib17","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1016\/j.vaccine.2005.07.001","article-title":"Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals","volume":"23","author":"Gradoni","year":"2005","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.vaccine.2007.11.021_bib18","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum","volume":"23","author":"Rafati","year":"2005","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2007.11.021_bib19","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.vaccine.2005.12.039","article-title":"Vaccination with a preparation based on recombinant cysteine peptidases and canine IL-12 does not protect dogs from infection with Leishmania infantum","volume":"24","author":"Poot","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.021_bib20","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.vaccine.2006.10.036","article-title":"Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis","volume":"25","author":"Carrillo","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.021_bib21","series-title":"Third World Congress on Leishmaniasis Palermo","first-page":"178","article-title":"Immunization with H1 and HASPB1 leishmania proteins protect dogs against experimental canine leishmaniasis","author":"Moreno","year":"2005"},{"key":"10.1016\/j.vaccine.2007.11.021_bib22","doi-asserted-by":"crossref","unstructured":"Moreno J, Nieto J, Masina S, Canavate C, Cruz I, Chicharro C, et al. Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis. Vaccine 2007 Jun 4.","DOI":"10.1016\/j.vaccine.2007.05.010"},{"issue":"11","key":"10.1016\/j.vaccine.2007.11.021_bib23","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.vaccine.2005.10.052","article-title":"Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs","volume":"24","author":"Saldarriaga","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.021_bib24","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/eji.1830190712","article-title":"Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis","volume":"19","author":"Liew","year":"1989","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2007.11.021_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1600-065X.1982.tb00378.x","article-title":"The in vitro generation and functional analysis of murine T cell populations and clones specific for a protozoan parasite, Leishmania tropica","volume":"61","author":"Louis","year":"1982","journal-title":"Immunol Rev"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.021_bib26","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.4049\/jimmunol.147.9.3149","article-title":"IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis","volume":"147","author":"Scott","year":"1991","journal-title":"J Immunol"},{"issue":"16","key":"10.1016\/j.vaccine.2007.11.021_bib27","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1073\/pnas.88.16.7011","article-title":"Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis","volume":"88","author":"Heinzel","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.021_bib28","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4049\/jimmunol.147.5.1653","article-title":"Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines","volume":"147","author":"Holaday","year":"1991","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.021_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1084\/jem.178.2.567","article-title":"Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice","volume":"178","author":"Scharton","year":"1993","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.021_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/IAI.71.1.401-410.2003","article-title":"Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis","volume":"71","author":"Ahmed","year":"2003","journal-title":"Infect Immunity"},{"issue":"5210","key":"10.1016\/j.vaccine.2007.11.021_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protective Leishmania antigen","volume":"268","author":"Mougneau","year":"1995","journal-title":"Science (New York, NY)"},{"issue":"5144","key":"10.1016\/j.vaccine.2007.11.021_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.7904381","article-title":"The adjuvant effect of interleukin-12 in a vaccine against Leishmania major","volume":"263","author":"Afonso","year":"1994","journal-title":"Science (New York, NY)"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.021_bib33","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major","volume":"186","author":"Gurunathan","year":"1997","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.021_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/iai.62.1.229-235.1994","article-title":"Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum","volume":"62","author":"Pinelli","year":"1994","journal-title":"Infect Immunity"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.021_bib35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-3024.1992.tb00026.x","article-title":"Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs","volume":"14","author":"Cabral","year":"1992","journal-title":"Parasite Immunol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.11.021_bib36","first-page":"473","article-title":"Demonstration of natural Leishmania infection in asymptomatic dogs in the absence of specific humoral immunity","volume":"70","author":"Cabral","year":"1993","journal-title":"Archives de l\u2019Institut Pasteur de Tunis"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.021_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3024.2006.00840.x","article-title":"Immunology of canine leishmaniasis","volume":"28","author":"Barbieri","year":"2006","journal-title":"Parasite Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.021_bib38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/AAC.40.1.253","article-title":"Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the l-arginine nitric oxide pathway","volume":"40","author":"Vouldoukis","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2007.11.021_bib39","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.021_bib40","first-page":"263","article-title":"Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery","volume":"3","author":"Sutter","year":"2003","journal-title":"Current Drug Targets"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2007.11.021_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"Drexler","year":"1998","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.021_bib42","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.micinf.2005.10.004","article-title":"MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis","volume":"8","author":"Perez-Jimenez","year":"2006","journal-title":"Microbes Infect\/Institut Pasteur"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.021_bib43","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1286-4579(01)01426-5","article-title":"Protective immune response against cutaneous leishmaniasis by prime\/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36\/LACK and IL-12 in combination with purified p36","volume":"3","author":"Gonzalo","year":"2001","journal-title":"Microbes Infect\/Institut Pasteur"},{"issue":"1-2","key":"10.1016\/j.vaccine.2007.11.021_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-2427(02)00128-9","article-title":"Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis","volume":"88","author":"Guarga","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.021_bib45","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/JCM.02297-05","article-title":"Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis","volume":"44","author":"Cruz","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2007.11.021_bib46","series-title":"Molecular cloning. A laboratory manual","author":"Maniatis","year":"1982"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.11.021_bib47","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vetpar.2006.01.011","article-title":"Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis","volume":"137","author":"Francino","year":"2006","journal-title":"Vet Parasitol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.021_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-3024.1995.tb00914.x","article-title":"Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites","volume":"17","author":"Deplazes","year":"1995","journal-title":"Parasite Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.11.021_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-4017(00)00223-5","article-title":"The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection","volume":"90","author":"Solano-Gallego","year":"2000","journal-title":"Vet Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.11.021_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-2427(02)00134-4","article-title":"Cytokine expression during the outcome of canine experimental infection by Leishmania infantum","volume":"88","author":"Santos-Gomes","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.021_bib51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-3024.1991.tb00550.x","article-title":"An experimental model for canine visceral leishmaniasis","volume":"13","author":"Abranches","year":"1991","journal-title":"Parasite Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.11.021_bib52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0304-4017(00)00313-7","article-title":"Infectivity of promastigotes and amastigotes of Leishmania infantum in a canine model for leishmaniosis","volume":"92","author":"Campino","year":"2000","journal-title":"Vet Parasitol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.11.021_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0165-2427(95)05434-8","article-title":"Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis","volume":"48","author":"Martinez-Moreno","year":"1995","journal-title":"Vet Immunol Immunopathol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.021_bib54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1471-4922(02)02347-4","article-title":"Canine leishmaniasis: epidemiological risk and the experimental model","volume":"18","author":"Moreno","year":"2002","journal-title":"Trends Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.021_bib55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-2427(98)00213-X","article-title":"Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis","volume":"67","author":"Nieto","year":"1999","journal-title":"Vet Immunol Immunopathol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.021_bib56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-4017(03)00132-8","article-title":"A follow-up of Beagle dogs intradermally infected with Leishmania chagasi in the presence or absence of sand fly saliva","volume":"114","author":"Paranhos-Silva","year":"2003","journal-title":"Vet Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.11.021_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-4017(99)00084-9","article-title":"Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate","volume":"84","author":"Riera","year":"1999","journal-title":"Vet Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.021_bib58","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.rvsc.2005.09.011","article-title":"Parasite density and impaired biochemical\/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis","volume":"81","author":"Reis","year":"2006","journal-title":"Res Vet Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.021_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1590\/S0074-02762004000200014","article-title":"Comparison between splenic and lymph node aspirations as sampling methods for the parasitological detection of Leishmania chagasi infection in dogs","volume":"99","author":"Barrouin-Melo","year":"2004","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.021_bib60","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4269\/ajtmh.2004.70.618","article-title":"Organ-specific immunity in canine visceral leishmaniasis: analysis of symptomatic and asymptomatic dogs naturally infected with Leishmania chagasi","volume":"70","author":"Sanchez","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"33","key":"10.1016\/j.vaccine.2007.11.021_bib61","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1016\/j.vaccine.2007.06.005","article-title":"Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune vaccine","volume":"25","author":"Santos","year":"2007","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2007.11.021_bib62","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1016\/j.vaccine.2007.05.010","article-title":"Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis","volume":"25","author":"Moreno","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.021_bib63","doi-asserted-by":"crossref","unstructured":"Day MJ. Immunoglobulin G subclass distribution in canine leishmaniosis: a review and analysis of pitfalls in interpretation. Vet Parasitol 2007.","DOI":"10.1016\/j.vetpar.2007.03.037"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.11.021_bib64","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-2427(02)00311-2","article-title":"IgG subclass responses in a longitudinal study of canine visceral leishmaniasis","volume":"91","author":"Quinnell","year":"2003","journal-title":"Vet Immunol Immunopathol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.11.021_bib65","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.vetimm.2004.08.011","article-title":"Immunoglobulin G and E responses in various stages of canine leishmaniosis","volume":"103","author":"Iniesta","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.11.021_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-2427(97)00072-X","article-title":"Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs","volume":"59","author":"Bourdoiseau","year":"1997","journal-title":"Vet Immunol Immunopathol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.11.021_bib67","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0165-2427(01)00270-7","article-title":"Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis","volume":"79","author":"Leandro","year":"2001","journal-title":"Vet Immunol Immunopathol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.11.021_bib68","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.vetimm.2006.02.001","article-title":"Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi","volume":"112","author":"Reis","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.11.021_bib69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vetimm.2007.01.014","article-title":"Anti-Leishmania humoral and cellular immune responses in naturally infected symptomatic and asymptomatic dogs","volume":"117","author":"Cardoso","year":"2007","journal-title":"Vet Immunol Immunopathol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.11.021_bib70","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vetpar.2006.10.007","article-title":"Characterization of circulating lymphocyte subpopulations in canine leishmaniasis throughout treatment with antimonials and allopurinol","volume":"144","author":"Miranda","year":"2007","journal-title":"Vet Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.11.021_bib71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vetpar.2005.04.032","article-title":"Flow cytometric analysis of cellular immune responses in dogs experimentally infected with a North American isolate of Leishmania infantum","volume":"131","author":"Rosypal","year":"2005","journal-title":"Vet Parasitol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.021_bib72","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/eji.1830250619","article-title":"Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner","volume":"25","author":"Pinelli","year":"1995","journal-title":"Eur J Immunol"},{"issue":"2\u20134","key":"10.1016\/j.vaccine.2007.11.021_bib73","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-2427(99)00048-3","article-title":"Detection of canine cytokine gene expression by reverse transcription-polymerase chain reaction","volume":"69","author":"Pinelli","year":"1999","journal-title":"Vet Immunol Immunopathol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07013102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07013102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:15:36Z","timestamp":1759400136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07013102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0264410X07013102"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}